134 related articles for article (PubMed ID: 661568)
1. Biphasic effect of somatostatin on oral glucose tolerance in maturity-onset diabetes.
Tamborlane WV; Sherwin RS; Hendler R; Felig P
Metabolism; 1978 Jul; 27(7):849-53. PubMed ID: 661568
[TBL] [Abstract][Full Text] [Related]
2. Metabolic effects of somatostatin in maturity-onset diabetes.
Tamborlane WV; Sherwin RS; Hendler R; Felig P
N Engl J Med; 1977 Jul; 297(4):181-3. PubMed ID: 876274
[TBL] [Abstract][Full Text] [Related]
3. Influence of somatostatin on carbohydrate disposal and absorption in diabetes mellitus.
Wahren J
Lancet; 1976 Dec; 2(7997):1213-6. PubMed ID: 63040
[TBL] [Abstract][Full Text] [Related]
4. Glucose homeostasis during prolonged suppression of glucagon and insulin secretion by somatostatin.
Sherwin RS; Hendler R; DeFronzo R; Wahren J; Felic P
Proc Natl Acad Sci U S A; 1977 Jan; 74(1):348-52. PubMed ID: 264686
[TBL] [Abstract][Full Text] [Related]
5. Somatostatin in maturity-onset diabetes.
Christensen SE; Hansen AP; Lundbaek K
Diabetes; 1978 Oct; 27(10):1013-9. PubMed ID: 700257
[TBL] [Abstract][Full Text] [Related]
6. The diabetogenic action of somatostatin in healthy subjects and in maturity onset diabetics.
Waldhäusl W; Bratusch-Marrain P; Dudczak R; Deutsch E
J Clin Endocrinol Metab; 1977 May; 44(5):876-83. PubMed ID: 870515
[TBL] [Abstract][Full Text] [Related]
7. The inhibitory effect of somatostatin on growth hormone, insulin and glucagon secretion in diabetes mellitus.
Ward FR; Leblanc H; Yen SS
J Clin Endocrinol Metab; 1975 Sep; 41(3):527-32. PubMed ID: 1159060
[TBL] [Abstract][Full Text] [Related]
8. Antidiabetic action of somatostatin after oral glucose loading: due to suppression of glucagon and growth hormone or of intestinal carbohydrate absorption?
Bratusch-Marrain P; Vierhapper H; Grubeck-Loebenstein B; Waldhäusl W; Nowotny P
Horm Metab Res; 1981 Jun; 13(6):305-9. PubMed ID: 6114914
[TBL] [Abstract][Full Text] [Related]
9. Abnormal pancreatic glucagon secretion and postprandial hyperglycemia in diabetes mellitus.
Gerich JE; Lorenzi M; Karam JH; Schneider V; Forsham PH
JAMA; 1975 Oct; 234(2):159-5. PubMed ID: 1242153
[TBL] [Abstract][Full Text] [Related]
10. Somatostatin and diabetes mellitus: the role of glucagon in diabetic hyperglycemia and glucose intolerance.
Wahren J
Scand J Clin Lab Invest; 1976 Oct; 36(6):497-503. PubMed ID: 1006141
[No Abstract] [Full Text] [Related]
11. Effect of intermittent endogenous hyperglucagonemia on glucose homeostasis in normal and diabetic man.
Rizza R; Verdonk C; Miles J; Service FJ; Gerich J
J Clin Invest; 1979 Jun; 63(6):1119-23. PubMed ID: 447838
[TBL] [Abstract][Full Text] [Related]
12. Effect of the somatostatin analog D-Trp8,D-Cys14 on glucose insulin, pancreatic glucagon and growth hormone plasma levels in acromegalics and mild diabetics.
Trovati M; Massara F; Camanni F; Molinatti GM; Lorenzati R; Pagano GF
J Endocrinol Invest; 1980; 3(2):189-92. PubMed ID: 6104680
[TBL] [Abstract][Full Text] [Related]
13. Influence of basal insulin and glucagon secretion on potassium and sodium metabolism. Studies with somatostatin in normal dogs and in normal and diabetic human beings.
DeFronzo RA; Sherwin RS; Dillingham M; Hendler R; Tamborlane WV; Felig P
J Clin Invest; 1978 Feb; 61(2):472-9. PubMed ID: 621284
[TBL] [Abstract][Full Text] [Related]
14. Insulin, glucagon, and somatostatin in normal physiology and diabetes mellitus.
Felig P; Wahren J; Sherwin R; Hendler R
Diabetes; 1976 Dec; 25(12):1091-9. PubMed ID: 992227
[TBL] [Abstract][Full Text] [Related]
15. Effect of a 12-hour subcutaneous infusion of somatostatin-14 on blood glucose, insulin and glucagon levels in healthy subjects and insulin dependent diabetics.
Villaume C; Beck B; Kolopp M; Toussain P; Debry G
Biomed Pharmacother; 1986; 40(2):61-4. PubMed ID: 2875745
[TBL] [Abstract][Full Text] [Related]
16. The role of glucagon in the pathogenesis of the endogenous hyperglycemia of diabetes mellitus.
Sakurai H; Dobbs RE; Unger RH
Metabolism; 1975 Nov; 24(11):1287-97. PubMed ID: 1186499
[TBL] [Abstract][Full Text] [Related]
17. Effects of physiologic levels of glucagon and growth hormone on human carbohydrate and lipid metabolism. Studies involving administration of exogenous hormone during suppression of endogenous hormone secretion with somatostatin.
Gerich JE; Lorenzi M; Bier DM; Tsalikian E; Schneider V; Karam JH; Forsham PH
J Clin Invest; 1976 Apr; 57(4):875-84. PubMed ID: 820717
[TBL] [Abstract][Full Text] [Related]
18. Effects of soy polysaccharide on postprandial plasma glucose, insulin, glucagon, pancreatic polypeptide, somatostatin, and triglyceride in obese diabetic patients.
Tsai AC; Vinik AI; Lasichak A; Lo GS
Am J Clin Nutr; 1987 Mar; 45(3):596-601. PubMed ID: 2881482
[TBL] [Abstract][Full Text] [Related]
19. Glucose intolerance in thyrotoxicosis roles of insulin, glucagon and somatostatin.
Lam KS; Yeung RT; Ho PW; Lam SK
Acta Endocrinol (Copenh); 1987 Feb; 114(2):228-34. PubMed ID: 2881418
[TBL] [Abstract][Full Text] [Related]
20. Effect of a long acting glucagon selective somatostatin analogue on plasma glucose, insulin and glucagon levels in the anaesthetized rat during arginine infusion.
Lien E; Sarantakis D
Diabetologia; 1979 Jul; 17(1):59-64. PubMed ID: 467854
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
